Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glycosaminoglycans enhance complement hemolytic efficiency: theoretical considerations for GAG-complement-saliva

N S Chang, R J Boackle

    Molecular Immunology
    |August 1, 1986
    PubMed
    Summary

    Glycosaminoglycans (GAGs) regulate complement activation in human serum by restricting spontaneous complement consumption in low ionic strength buffer. Highly charged GAGs conserve complement activity, enhancing subsequent hemolytic function.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A cascade of protein aggregation bombards mitochondria for neurodegeneration and apoptosis under WWOX deficiency.

    Cell death & disease·2015
    Same author

    WWOX suppresses autophagy for inducing apoptosis in methotrexate-treated human squamous cell carcinoma.

    Cell death & disease·2013
    Same author

    Characterization of serum adhesive proteins that block tumor necrosis factor-mediated cell death.

    Cell death and differentiation·2006
    Same author

    Biomass conversion to mixed alcohol fuels using the MixAlco process.

    Applied biochemistry and biotechnology·2004
    Same author

    Influence of maternal serum levels of vitamins C and E during the second trimester on birth weight and length.

    European journal of clinical nutrition·2004
    Same author

    Acquired activated protein C resistance, high tissue factor expression, and hyper-homocysteinemia in systemic lupus erythematosus.

    American journal of hematology·2003

    Area of Science:

    • Immunology
    • Biochemistry
    • Complement System

    Background:

    • Human serum spontaneously activates complement (C) in low ionic strength buffer (LIS) at 37°C, evidenced by C4 and C3 conversion.
    • This spontaneous activation leads to non-specific fluid phase complement consumption.

    Purpose of the Study:

    • To investigate the role of glycosaminoglycans (GAGs) in modulating spontaneous complement activation in LIS.
    • To determine how GAGs affect complement-mediated hemolytic activity and consumption.

    Main Methods:

    • Human serum was diluted and pre-incubated in low ionic strength buffer (LIS) with various glycosaminoglycans (GAGs).
    • Complement activation was assessed by C4 and C3 electrophoretic conversion.
    • Hemolytic activity of residual complement was measured.

    Related Experiment Videos

    Main Results:

    • Most GAG species restricted non-specific fluid phase complement consumption in LIS, conserving complement and enhancing residual hemolytic activity.
    • The regulatory capacity of GAGs depended on their charge; heparin, dermatan sulfate, and dextran sulfate showed significant effects.
    • High concentrations of less charged GAGs (hyaluronic acid, chondroitin-4-sulfate) also restricted fluid phase consumption, preserving hemolytic activity.

    Conclusions:

    • GAGs regulate spontaneous complement activation and consumption in low ionic strength conditions.
    • The charge and structural integrity of GAGs are crucial for their complement-modulating effects.
    • GAGs may potentiate C1 inhibitor function or directly affect C1, potentially by creating a localized high-ionic-strength environment.